Shawn Guse, who held the role of interim vice president of global sales since August 25, 2008, will take on other executive responsibilities within the organization, including continuing as the CEO of TomoTherapy's proton therapy development subsidiary, Compact Particle Acceleration Corporation.
"Shawn has stepped in and provided valuable leadership in a critical role during his transition," said Dr. Robertson. "We appreciate Shawn's versatile talents and excellent leadership skills."
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy HiArt treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HiArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and HiArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.
Read the full story at http://www.prweb.com/releases/vice_president/global_sales/prweb1664754.htm
| Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved |